EMRYPKEN Trademark

Trademark Overview


On Thursday, May 18, 2023, a trademark application was filed for EMRYPKEN with the United States Patent and Trademark Office. The USPTO has given the EMRYPKEN trademark a serial number of 98002552. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Monday, April 21, 2025. This trademark is owned by Genzyme Corporation. The EMRYPKEN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the prevention and treatment of immunological diseases; pharmaceutical preparations for use in the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of Amyotrophic Lateral Sclerosis and Multiple Sclerosis and Alzheimer's
emrypken

General Information


Serial Number98002552
Word MarkEMRYPKEN
Filing DateThursday, May 18, 2023
Status731 - SECOND EXTENSION - GRANTED
Status DateMonday, April 21, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 2, 2024

Trademark Statements


Goods and ServicesPharmaceutical products for the prevention and treatment of immunological diseases; pharmaceutical preparations for use in the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of Amyotrophic Lateral Sclerosis and Multiple Sclerosis and Alzheimer's

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 20, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGenzyme Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02141

Party NameGenzyme Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02141

Trademark Events


Event DateEvent Description
Thursday, June 8, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 22, 2023NEW APPLICATION ENTERED
Friday, June 2, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, June 8, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 8, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 20, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 6, 2023ASSIGNED TO LIE
Tuesday, November 7, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 7, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 12, 2024ASSIGNED TO EXAMINER
Friday, February 23, 2024EXAMINERS AMENDMENT -WRITTEN
Friday, February 23, 2024EXAMINERS AMENDMENT E-MAILED
Friday, February 23, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, February 23, 2024EXAMINER'S AMENDMENT ENTERED
Friday, February 23, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 4, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, March 13, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 2, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 22, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 22, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 22, 2024SOU EXTENSION 1 FILED
Tuesday, October 22, 2024SOU EXTENSION 1 GRANTED
Monday, April 21, 2025SOU TEAS EXTENSION RECEIVED
Monday, April 21, 2025SOU EXTENSION 2 FILED
Monday, April 21, 2025SOU EXTENSION 2 GRANTED
Monday, April 21, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED